Fair allocation of healthcare research funds by the European Union?-Reference-Cited by-同舟云学术

Fair allocation of healthcare research funds by the European Union?

Published:2018-10-25 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Kaló Zoltán^ORCID,van den Akker Loek Hendrik Matheo,Vokó Zoltán,Csanádi Marcell^ORCID,Pitter György János^ORCID

Abstract

AbstractThis study aimed to investigate the distribution of European Union (EU) healthcare research grants across EU countries, and to study the effect of the potential influencing factors on grant allocation. We analysed publicly available data on healthcare research grants from the 7th Framework Programme and the Horizon 2020 Programme allocated to beneficiaries between 2007 and 2016. Grant allocation was analysed at the beneficiary-, country-, and country group-level (EU-15 versus newer Member States, defined as EU-13). The investigated country-level explanatory variables included GDP per capita, population size, overall disease burden, and healthcare research excellence. Grant amounts per 100,000 inhabitants was used as an outcome variable in the regression analyses.Research funds were disproportionally allocated to EU-15 versus the EU-13, as 96.9% of total healthcare grants were assigned to EU-15 countries. At the beneficiary level, EU funding was positively influenced by participating in previous grants. The average grant amount per beneficiary was higher for EU-15 organizations. In univariate regression analyses at the country level, higher GDP per capita (p<0.001) and better medical research excellence (p<0.001) were associated with more EU funding, and a higher disease burden was associated with less EU funding (p=0.003). In the multiple regression analysis GDP per capita (p=0.002) and research excellence (p<0.001) had a significant positive association with EU funding. Population size had an inverted U-shaped relationship with EU funding for healthcare research, having the largest per capita funding in second and the third quartiles (p=0.03 and p=0.02).The uneven allocation of healthcare research funds across EU countries was influenced by GDP per capita, medical research excellence and population size. Wealthier countries with an average population size and strong research excellence in healthcare had more EU funding for healthcare research. Higher disease burden apparently was not associated with more EU research funding.

Publisher

Cold Spring Harbor Laboratory

Reference25 articles.

1. Martin B. The changing social contract for science and the evolution of the university. In: Geuna A , Salter A , Steinmueller W , eds. Science and Innovation: Rethinking the Rationales for Funding and Governance. Cheltenham: Edward Elgar 2003:7–29.

2. The European Union. Research and innovation - The European Union Explained. 2014. Available at: https://europa.eu/european-union/sites/europaeu/files/research_en.pdf (accessed November 2017).

3. M Suhrcke , M McKee , R Sauto Arce , S Tsolova , J Mortensen . The contribution of health to the economy in the European Union. European Commission. Brussels 2005. Available at: https://ec.europa.eu/health/archive/ph_overview/documents/health_economy_en.pdf (accessed September 2018)

4. Greer, S. L. , Fahy, N. , Elliott, H. A. , Wismar, M. , Jarman, H. , Palm, W. Everything you always wanted to know about European Union health policies but were afraid to ask. European Observatory on Health Systems and Policies. 2014. Available at: http://www.euro.who.int/data/assets/pdf_file/0008/259955/Everything-you-always-wanted-to-know-about-European-Union-health-policies-but-were-afraid-to-ask.pdf (accessed September 2018)